HOXA10 and cancer: Subsequently, an investigation of non-coding transcripts in pan-cancer confirmed the prognostic roles of the onco-lncRNA HOXA10-AS in glioblastomas, revealing that its upregulation was associated with poor prognosis in IDH-mutant (MUT) glioblastoma and isocitrate dehydrogenase (IDH)-wild-type (WT) patients [26].